{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T14:14:30Z","timestamp":1770905670008,"version":"3.50.1"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Acute bronchitis is caused by an infection of the lower respiratory tract, resulting in considerable distress of patients and substantial economic costs due to lost workdays. Although acute bronchitis is mostly caused by viruses, antibiotics are frequently used. The aim of this study was to evaluate whether a prescription of EPs 7630 for patients with acute bronchitis is associated with a lower recurrence rate of the disease or fewer complications, a reduced need for antibiotic therapy, or fewer lost workdays.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A retrospective analysis was conducted using the IQVIA\u2122 Disease Analyzer database, which contains information from nearly 3,000 office-based physicians, representing around 3%\u20135% of all German practices. We analyzed the rates of recurrence of acute bronchitis, antibiotic prescription, duration of sick leave, and incidence of complications (pneumonia, chronic bronchitis) with regard to their association with prescriptions of EPs 7630, ambroxol, acetylcysteine, or antibiotics for acute bronchitis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of the 376,366 patients suffering from acute bronchitis between January 2005 and December 2022, 1,994 received prescription of EPs 7630, 14,952 ambroxol, 24,149 acetylcysteine, and 335,271 antibiotics. EPs 7630 prescription was associated with a significantly lower likelihood of re-consultation due to acute bronchitis within 365 days compared to ambroxol (HR: 0.74; 95% CI: 0.65\u20130.83), acetylcysteine (HR: 0.78; 95% CI: 0.69\u20130.88), and antibiotics (HR: 0.75; 95% CI: 0.67\u20130.85) (p &amp;lt; 0.001 each). The incidence of an antibiotic prescription following an initial EPs 7630 prescription was significantly lower compared to acetylcysteine (HR: 0.89; 95% CI: 0.81\u20130.98) (p = 0.020). EPs 7630 was also associated with a lower risk of pneumonia and chronic bronchitis and a lower proportion of patients with sick leave lasting &amp;gt;3 and \u22657 days, respectively, compared to the other prescription groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Prescribing EPs 7630 is associated with a lower incidence of disease recurrence and complications, a reduced need for antibiotic therapy, and a reduction in lost workdays. The results of this retrospective analysis thus emphasize the overall benefits of EPs 7630 as an effective treatment option for managing acute bronchitis.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2025.1652203","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T05:33:28Z","timestamp":1757914408000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Prescription of EPs 7630 is associated with short- and long-term benefits in acute bronchitis: a real-world data analysis"],"prefix":"10.3389","volume":"16","author":[{"given":"Adrian","family":"Gillissen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thorsten","family":"Reineke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Burkart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Funk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles Christian","family":"Adarkwah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karel","family":"Kostev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.phymed.2007.11.023","article-title":"Pelargonium sidoides for acute bronchitis: a systematic review and meta-analysis","volume":"15","author":"Agbabiaka","year":"2008","journal-title":"Phytomedicine"},{"key":"B2","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.phymed.2009.02.001","article-title":"Erratum to \u2018\u2018Pelargonium sidoides for acute bronchitis: a systematic review and meta-analysis\u2019\u2019 [phytomedicine 15 (2008) 378\u2013385]","volume":"16","author":"Agbabiaka","year":"2009","journal-title":"Phytomedicine"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1055\/a-2321-8275","article-title":"Antibiotic prescription rates for respiratory tract infections treated in the outpatient sector based on routine data from a German health insurance company","author":"Arens","year":"2024","journal-title":"Gesundheitswesen"},{"key":"B4","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.phymed.2015.03.004","article-title":"Evaluation of pharmacodynamic activities of EPs\u00ae 7630, a special extract from roots of Pelargonium sidoides, in animals models of cough, secretolytic activity and acute bronchitis","volume":"22","author":"Bao","year":"2015","journal-title":"Phytomedicine"},{"key":"B5","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1378\/chest.122.2.603","article-title":"Economic burden of respiratory infections in an employed population","volume":"122","author":"Birnbaum","year":"2002","journal-title":"Chest"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e28686","DOI":"10.1002\/jmv.28686","article-title":"Omicron-induced interferon signaling prevents influenza A H1N1 and H5N1 virus infection","volume":"95","author":"Bojkova","year":"2023","journal-title":"J. Med. Virol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"95S-103S","DOI":"10.1378\/chest.129.1_suppl.95S","article-title":"Chronic cough due to acute bronchitis: ACCP evidence-based clinical practice guidelines","volume":"129","author":"Braman","year":"2006","journal-title":"Chest"},{"key":"B8","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J. Chronic Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1455870","DOI":"10.3389\/fphar.2024.1455870","article-title":"Multiple mechanisms enable broad-spectrum activity of the Pelargonium sidoides root extract EPs 7630 against acute respiratory tract infections","volume":"15","author":"Cinatl","year":"2024","journal-title":"Front. Pharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e76691","DOI":"10.1371\/journal.pone.0076691","article-title":"Are patient views about antibiotics related to clinician perceptions, management and outcome? A multi-country study in outpatients with acute cough","volume":"8","author":"Coenen","year":"2013","journal-title":"PLoS One"},{"key":"B11","doi-asserted-by":"publisher","first-page":"g5238","DOI":"10.1136\/bmj.g5238","article-title":"GPs feel pressurised to prescribe unnecessary antibiotics, survey finds","volume":"349","author":"Cole","year":"2014","journal-title":"BMJ Clin. Res. ed."},{"key":"B12","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ijid.2022.09.036","article-title":"The effect of absent or deferred antibiotic treatment on complications of common infections in primary care","volume":"124","author":"Dahl\u00e9n","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"B13","volume-title":"Antimicrobial resistance in the EU\/EEA (EARS-Net) - annual epidemiological report 2019","year":"2020"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1214351","DOI":"10.3389\/fphar.2023.1214351","article-title":"In vitro and in vivo effects of Pelargonium sidoides DC. root extract EPs\u00ae 7630 and selected constituents against SARS-CoV-2 B.1, Delta AY.4\/AY.117 and Omicron BA.2","volume":"14","author":"Emanuel","year":"2023","journal-title":"Front. Pharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1093\/fampra\/cmu075","article-title":"Illness perception and related behaviour in lower respiratory tract infections - a European study","volume":"32","author":"Hordijk","year":"2015","journal-title":"Fam. Pract."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1136\/bmj.317.7170.1433","article-title":"Acute bronchitis and clinical outcome three years later: prospective cohort study","volume":"317","author":"J\u00f3nsson","year":"1998","journal-title":"BMJ Clin. Res. ed."},{"key":"B17","doi-asserted-by":"publisher","first-page":"88","DOI":"10.36118\/pharmadvances.2022.33","article-title":"Treatment of sore throat and hoarseness with Pelargonium sidoides extract EPs 7630: a meta-analysis","volume":"4","author":"Kamin","year":"2022","journal-title":"Pharmadvances"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40816-015-0003-2","article-title":"Phytotherapy in acute bronchitis: what is the evidence?","volume":"1","author":"Kardos","year":"2015","journal-title":"Clin. Phytoscience"},{"key":"B19","doi-asserted-by":"publisher","first-page":"868","DOI":"10.4081\/mrm.2022.868","article-title":"Effects of Pelargonium sidoides extract EPs 7630 on acute cough and quality of life \u2013 a meta-analysis of randomized, placebo-controlled trials","volume":"17","author":"Kardos","year":"2022","journal-title":"Multidiscip. Respir. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s13643-024-02649-3","article-title":"Antimicrobial prescription pattern and appropriateness for respiratory tract infection in outpatients: a systematic review and meta-analysis","volume":"13","author":"Kasse","year":"2024","journal-title":"Syst. Rev."},{"key":"B21","doi-asserted-by":"publisher","first-page":"982","DOI":"10.3390\/antibiotics13100982","article-title":"Investigation into the effectiveness of an herbal combination (Angocin\u00aeAnti-Infekt N) in the therapy of acute bronchitis: a retrospective real-world cohort study","volume":"13","author":"Kassner","year":"2024","journal-title":"Antibiot. (Basel)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3390\/antibiotics10040455","article-title":"Prevalence of and factors associated with antibiotic prescriptions in patients with acute lower and upper respiratory tract infections - a Case-Control Study","volume":"10","author":"Kern","year":"2021","journal-title":"Antibiot. (Basel)"},{"key":"B23","first-page":"560","article-title":"Acute bronchitis","volume":"94","author":"Kinkade","year":"2016","journal-title":"Am. Fam. Physician"},{"key":"B24","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1055\/a-0655-8058","article-title":"Acute Respiratory Tract Infections\/Acute Bronchitis","volume":"144","author":"Kleibrink","year":"2019","journal-title":"Dtsch. Med. Wochenschr"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.3390\/ph4101295","article-title":"Antimicrobial, antiviral and immunomodulatory activity studies of Pelargonium sidoides (EPs\u00ae 7630) in the context of health promotion","volume":"4","author":"Kolodziej","year":"2011","journal-title":"Pharm. (Basel)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1078\/1433-187x-00307","article-title":"Pharmacological profile of extracts of Pelargonium sidoides and their constituents","volume":"10","author":"Kolodziej","year":"2003","journal-title":"Phytomedicine"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.3390\/antibiotics12101491","article-title":"Changes in the prescription of antibiotics and phytopharmaceuticals in children treated for acute upper and lower respiratory tract infections in pediatric practices in Germany in 2013, 2018, and 2022","volume":"12","author":"Kostev","year":"2023","journal-title":"Antibiot. (Basel)"},{"key":"B28","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3238\/arztebl.2016.0597","article-title":"Propensity score: an alternative method of analyzing treatment effects","volume":"113","author":"Kuss","year":"2016","journal-title":"Dtsch. Arztebl Int."},{"key":"B29","doi-asserted-by":"publisher","first-page":"21501319231204436","DOI":"10.1177\/21501319231204436","article-title":"Prevalence of upper respiratory tract infections before, during, and after the COVID-19 pandemic in Germany: a cross-sectional study of 2 167 453 outpatients","volume":"14","author":"Loosen","year":"2023","journal-title":"J. Prim. Care Community Health"},{"key":"B30","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1136\/thorax.56.2.109","article-title":"Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community","volume":"56","author":"Macfarlane","year":"2001","journal-title":"Thorax"},{"key":"B31","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1080\/00325481.2020.1751497","article-title":"Reduced antibiotic use after initial treatment of acute respiratory infections with phytopharmaceuticals-a retrospective cohort study","volume":"132","author":"Martin","year":"2020","journal-title":"Postgrad. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1055\/s-0030-1264267","article-title":"Safety and tolerability of EPs\u00ae 7630 (Umckaloabo\u00ae)","volume":"76","author":"Matthys","year":"2010","journal-title":"Planta Medica"},{"key":"B33","doi-asserted-by":"publisher","first-page":"142","DOI":"10.4172\/2167-1052.1000142","article-title":"Safety and tolerability of EPs\u00ae 7630 in clinical trials","volume":"2","author":"Matthys","year":"2013","journal-title":"Adv. Pharmacoepidemiol Drug Saf."},{"key":"B34","doi-asserted-by":"publisher","first-page":"4","DOI":"10.15406\/jlprr.2016.03.00068","article-title":"EPs\u00ae 7630 in acute respiratory tract infections \u2013 a systematic review and meta-analysis of randomized clinical trials","volume":"3","author":"Matthys","year":"2016","journal-title":"J. Lung Pulm. Respir. Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"914","DOI":"10.4081\/mrm.2023.914","article-title":"Effects of EPs 7630 on the duration of inability to work in acute bronchitis - a meta-analysis","volume":"18","author":"Matthys","year":"2023","journal-title":"Multidiscip. Respir. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1007\/s11606-024-08758-y","article-title":"Antibiotics not associated with shorter duration or reduced severity of acute lower respiratory tract infection","volume":"39","author":"Merenstein","year":"2024","journal-title":"J. Gen. Intern Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.phymed.2010.09.008","article-title":"Investigation of the influence of EPs\u00ae 7630, a herbal drug preparation from Pelargonium sidoides, on replication of a broad panel of respiratory viruses","volume":"18","author":"Michaelis","year":"2011","journal-title":"Phytomedicine"},{"key":"B38","doi-asserted-by":"publisher","first-page":"757666","DOI":"10.3389\/fphar.2021.757666","article-title":"Antiviral and immunomodulatory effects of Pelargonium sidoides DC. root extract EPs\u00ae 7630 in SARS-CoV-2-infected human lung cells","volume":"12","author":"Papies","year":"","journal-title":"Front. Pharmacol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"814452","DOI":"10.3389\/fphar.2021.814452","article-title":"Corrigendum: antiviral and immunomodulatory effects of Pelargonium sidoides DC. root extract EPs\u00ae 7630 in SARS-CoV-2-infected human lung cells","volume":"12","author":"Papies","year":"","journal-title":"Front. Pharmacol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1177\/0003489420918266","article-title":"Herbal drug EPs\u00ae 7630 versus amoxicillin in patients with uncomplicated acute bacterial rhinosinusitis: a randomized, open-label study","volume":"129","author":"Peri\u0107","year":"2020","journal-title":"Ann. Otol. Rhinol. Laryngol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"459","DOI":"10.5414\/CP203320","article-title":"Basic characteristics and representativeness of the German Disease Analyzer database","volume":"56","author":"Rathmann","year":"2018","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e0210702","DOI":"10.1371\/journal.pone.0210702","article-title":"Pelargonium sidoides radix extract EPs\u00ae 7630 reduces rhinovirus infection through modulation of viral binding proteins on human bronchial epithelial cells","volume":"14","author":"Roth","year":"2019","journal-title":"PLoS One"},{"key":"B43","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3390\/ph14020172","article-title":"Up-regulated vitamin D receptor by Pelargonium sidoides extract EPs\u00ae 7630 contributes to rhinovirus defense in bronchial epithelial cells","volume":"14","author":"Roth","year":"2021","journal-title":"Pharm. (Basel)"},{"key":"B44","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1055\/s-2008-1074515","article-title":"A detailed view on the constituents of EPs\u00ae 7630","volume":"74","author":"Schoetz","year":"2008","journal-title":"Planta Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12875-023-02039-z","article-title":"The conceptualization of acute bronchitis in general practice - a fuzzy problem with consequences? A qualitative study in primary care","volume":"24","author":"Schubert","year":"2023","journal-title":"BMC Prim. Care"},{"key":"B46","doi-asserted-by":"publisher","first-page":"102613","DOI":"10.1016\/j.ctim.2020.102613","article-title":"Herbal medicine for acute bronchitis: a qualitative interview study of patients' and health professionals' views","volume":"55","author":"Soilemezi","year":"2020","journal-title":"Complement. Ther. Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"S84","DOI":"10.1016\/j.jclinepi.2013.01.013","article-title":"Prognostic score-based balance measures can be a useful diagnostic for propensity score methods in comparative effectiveness research","volume":"66","author":"Stuart","year":"2013","journal-title":"J. Clin. Epidemiol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.puhe.2021.12.006","article-title":"Investigation of the prevalence of non-COVID-19 infectious diseases during the COVID-19 pandemic","volume":"203","author":"Tanislav","year":"2022","journal-title":"Public Health"},{"key":"B49","doi-asserted-by":"publisher","first-page":"CD006323","DOI":"10.1002\/14651858.CD006323.pub3","article-title":"Pelargonium sidoides extract for treating acute respiratory tract infections","volume":"10","author":"Timmer","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1358879","DOI":"10.3389\/fphar.2024.1358879","article-title":"Long-term benefits of EPs\u00ae 7630 in patients with acute sinusitis: a real-world cohort study","volume":"15","author":"Tisch","year":"2024","journal-title":"Front. Pharmacol."},{"key":"B51","first-page":"277","article-title":"The antibiotic resistance crisis: part 1: causes and threats P & T","volume":"40","author":"Ventola","year":"2015"},{"key":"B52","first-page":"1508","article-title":"Bronchitis (acute)","volume":"2015","author":"Wark","year":"2015","journal-title":"BMJ Clin. Evid."},{"key":"B53","doi-asserted-by":"publisher","first-page":"e0138075","DOI":"10.1371\/journal.pone.0138075","article-title":"The Pelargonium sidoides extract EPs\u00ae 7630 drives the innate immune defense by activating selected MAP kinase pathways in human monocytes","volume":"10","author":"Witte","year":"2015","journal-title":"PLoS One"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1007\/s00109-020-01970-3","article-title":"The herbal extract EPs\u00ae 7630 increases the antimicrobial airway defense through monocyte-dependent induction of IL-22 in T cells","volume":"98","author":"Witte","year":"2020","journal-title":"J. Mol. Med. (Berl.)"},{"key":"B55","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1055\/a-1949-3397","article-title":"Acute respiratory tract infections and antibiotic prescriptions: what are patients' expectations?","volume":"102","author":"Wollny","year":"2023","journal-title":"Laryngorhinootologie"},{"key":"B56","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1055\/s-0043-1777092","article-title":"Effects of EPs 7630 on illness absence from childcare or school due to acute bronchitis\u2014a meta-analysis","volume":"19","author":"Zwiauer","year":"2024","journal-title":"J. Pediatr. Infect. Dis."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1652203\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T05:33:30Z","timestamp":1757914410000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1652203\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,15]]},"references-count":56,"alternative-id":["10.3389\/fphar.2025.1652203"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1652203","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,15]]},"article-number":"1652203"}}